However, acute exercise does not show benefit for generally inactive people
THURSDAY, June 16, 2022 (HealthDay News) — Physical activity and acute exercise offer some benefit for influenza vaccination response, according to a review published online June 15 in PLOS ONE.
Erika Bohn-Goldbaum, from the University of Sydney, and colleagues conducted a systematic literature review to identify studies assessing the effect of physical activity and acute exercise (single bout of <60 minutes) on influenza vaccine antibody responses at four to six weeks.
Based on nine studies (550 participants), the researchers found that measures of antibody response tended to be higher in the acute-exercised participants versus rested controls and among physically active versus inactive individuals. Among all participants, physical activity significantly increased H1 strain seroconversion (adjusted odds ratio, 1.69) and titer response (adjusted odds ratio, 1.20) among the acute exercise group. Immunogenic response was frequently reduced with increasing age, while body mass index and sex had little to no effect. For interventions exercising the same arm in which the vaccine was administered, adjuvant effects were more pronounced.
“Though we found some benefit from either acute exercise or physical activity on antibody titer levels, our finding did not support our hypothesis: there was no added benefit of acute exercise to inactive participants,” the authors write.
Physical Activity Linked to Slower Cognitive, Motor Progression in Parkinson Disease
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate
Exercise Intervention Linked to Improved Attention, Memory in Breast Cancer
Exercise-Based Cardiac Rehab Beneficial for Coronary Heart Disease
Isometric Exercise Training Three Times a Week Preserves Cardiovascular Benefits
UACR, UPCR Provide Indistinguishable Prognostic Information in CKD
Strength Training Not Tied to Ventricular Arrhythmia in Those With Arrhythmogenic Cardiomyopathy
Use of SAMA, SABA Linked to Cardiovascular Events, Mortality in Asthma, COPD